BIOCHEMICAL BASIS FOR THE DIFFERENTIAL SENSITIVITY OF HUMAN T- AND B-LYMPHOCYTE LINES TO 5-FLUOROURACILPIPER AA; FOX RM.1982; CANCER RES.; USA; DA. 1982; VOL. 42; NO 9; PP. 3753-3760; BIBL. 49 REF.Article

DEOXYCOFORMYCIN-INDUCED RESPONSE IN CHRONIC LYMPHOCYTIC LEUKAEMIA: DEOXYADENOSINE TOXICITY IN NON-REPLICATING LYMPHOCYTESKEFFORD RF; FOX RM.1982; BR. J. HAEMATOL.; ISSN 0007-1048; GBR; DA. 1982; VOL. 50; NO 4; PP. 627-636; BIBL. 2 P.Article

PURINE DEOXYNUCLEOSIDE TOXICITY IN NONDIVIDING HUMAN LYMPHOID CELLSKEFFORD RF; FOX RM.1982; CANCER RES.; ISSN 0008-5472; USA; DA. 1982; VOL. 42; NO 1; PP. 324-330; BIBL. 47 REF.Article

PROLONGED OVIDUCT RETENTION OF IODIZED CONTRAST MEDIUM = RETENTION TUBAIRE PROLONGEE DE PRODUIT IODE DE CONTRASTEMALTER IJ; FOX RM.1972; OBSTETR. AND GYNECOL.; U.S.A.; DA. 1972; VOL. 40; NO 2; PP. 221-224; BIBL. 12REF.Article

PURINOGENIC LYMPHOCYTOTOXICITY: CLUES TO A WIDER CHEMOTHERAPEUTIC POTENTIAL FOR THE ADENOSINE DEAMINASE INHIBITORSKEFFORD RF; FOX RM.1983; CANCER CHEMOTHERAPY AND PHARMACOLOGY; ISSN 0344-5704; DEU; DA. 1983; VOL. 10; NO 2; PP. 73-78; BIBL. 52 REF.Article

ADVANCED MALE NON-SEMINOMATOUS GERM-CELL TUMOURS. COMBINATION CHEMOTHERAPY WITH CIS-PLATINUM, VINBLASTINE AND BLEOMYCINWOODS RL; FOX RM; TATTERSALL MHN et al.1979; MED. J. AUSTRAL.; AUS; DA. 1979; VOL. 2; NO 12; PP. 630-632; BIBL. 7 REF.Article

INTERCONVERSION OF DIFFERENT MOLECULAR WEIGHT FORMS OF HUMAN ERYTHROCYTE OROTIDYLATE DECARBOXYLASE.BROWN GK; FOX RM; O'SULLIVAN WJ et al.1975; J. BIOL. CHEM.; U.S.A.; DA. 1975; VOL. 250; NO 18; PP. 7352-7358; BIBL. 32 REF.Article

FATHER-SON TESTICULAR MALIGNANCY: DOES GENETIC ANTICIPATION OCCUR.RAGHAVAN D; JELIHOVSKY T; FOX RM et al.1980; CANCER; USA; DA. 1980; VOL. 45; NO 5; PP. 1005-1009; BIBL. 27 REF.Article

TREATMENT OF SMALL CELL BRONCHOGENIC CARCINOMA WITH VM-26WOODS RL; FOX RM; TATTERSALL MHN et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 11-12; PP. 2011-2013; BIBL. 10 REF.Article

MECHANISM OF DEOXYCYTIDINE RESINE OF THYMIDINE TOXICITY IN HUMAN T-LEUKEMIC LYMPHOCYTESFOX RM; TRIPP EH; TATTERSALL MHN et al.1980; CANCER RES.; USA; DA. 1980; VOL. 40; NO 5; PP. 1718-1721; BIBL. 17 REF.Article

INCORPORATION OF DEOXYNUCLEOTIDES INTO DNA BY DIETHYLAMINOETHYLDEXTRAN-TREATED LYMPHOCYTES.FOX RM; MYNDERSE JF; GOULIAN M et al.1977; BIOCHEMISTRY; U.S.A.; DA. 1977; VOL. 16; NO 20; PP. 4470-4477; BIBL. 41 REF.Article

EVIDENCE FOR A NEW MECHANISM OF CYTOTOXICITY OF 1-BETA -D ARABINOFURANOSYLCYTOSINEWOODCOCK DM; FOX RM; COOPER IA et al.1979; CANCER RES.; USA; DA. 1979; VOL. 39; NO 4; PP. 1418-1424; BIBL. 25 REF.Article

MALIGNANT HAEMANGIOPERICYTOMA: CASE REPORT AND ULTRASTRUCTURAL STUDYNEWLAND RC; MAXWELL LE; CONSTANCE TJ et al.1978; PATHOLOGY; AUS; DA. 1978; VOL. 10; NO 3; PP. 277-283; BIBL. 13 REF.Article

PERIPHERAL VASCULAR DISEASE AS A MODE OF PRESENTATION OF PSEUDOXANTHOMA ELASTICUM.WAHLQVIST ML; FOX RM; BEECH AM et al.1977; AUSTRAL. NEW ZEAL. J. MED.; AUSTRAL.; DA. 1977; VOL. 7; NO 5; PP. 523-525; BIBL. 9 REF.Article

METASTATIC ADENOCARCINOMAS OF UNKOWN PRIMARY SITE: A RANDOMIZED STUDY OF TWO COMBINATION-CHEMOTHERAPY REGIMENSWOODS RL; FOX RM; TATTERSALL MHN et al.1980; NEW ENGL. J. MED.; USA; DA. 1980; VOL. 303; NO 2; PP. 87-89; BIBL. 11 REF.Article

A RANDOMIZED STUDY OF ADJUVANT IMMUNOTHERAPY WITH LEVAMISOLE AND C. PARVUM IN OPERABLE NON-SMALL CELL LUNG CANCERFOX RM; WOODS RL; TATTERSALL MHN et al.1980; INT. J. RADIAT. ONCOL., BIOL., PHYS.; ISSN 0360-3016; USA; DA. 1980; VOL. 6; NO 8; PP. 1043-1045; BIBL. 8 REF.Conference Paper

A RANDOMIZED STUDY: SMALL CELL ANAPLASTIC LUNG CANCER TREATED BY COMBINATION CHEMOTHERAPY AND ADJUVANT RADIOTHERAPYFOX RM; WOODS RL; BRODIE GN et al.1980; INT. J. RADIAT. ONCOL., BIOL., PHYS.; ISSN 0360-3016; USA; DA. 1980; VOL. 6; NO 8; PP. 1083-1085; BIBL. 5 REF.Conference Paper

ANEMIA OF AZARIBINE IN THE TREATMENT OF PSORIASIS.CORNELL RC; MILSTEIN HG; FOX RM et al.1976; ARCH. DERMATOL.; U.S.A.; DA. 1976; VOL. 112; NO 12; PP. 1717-1723; BIBL. 23 REF.Article

G₁-PHASE ARREST OF CULTURED HUMAN LEUKEMIC T-CELLS INDUCED BY DEOXYADENOSINEFOX RM; KEFFORD RF; TRIPP EH et al.1981; CANCER RES.; ISSN 0008-5472; USA; DA. 1981; VOL. 41; NO 12; PART. 1; PP. 5141-5150; BIBL. 25 REF.Article

CANCER CHEMOTHERAPY - WHAT HAVE WE ACHIEVED.MILSTED RAV; FOX RM; TATTERSALL MHN et al.1980; LANCET; GBR; DA. 1980; NO 8182; PP. 1343-1346Article

COMBINATION CHEMOTHERAPY WITH VINCRISTINE, BLEOMYEIN, AND METHOTREXATE FOR ADVANCED HEAD AND NECK CANCERSWOODS RL; STEWART J; FOX RM et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 11-12; PP. 1997-1999; BIBL. 7 REF.Article

ALLOPURINOL MODULATION OF HIGH-DOSE FLUOROURACIL TOXICITYFOX RM; WOODS RL; TATTERSALL MHN et al.1979; CANCER TREATM. REV.; GBR; DA. 1979; VOL. 6; SUPPL.; PP. 143-147; BIBL. 8 REF.Conference Paper

NASCENT DNA FROM PHYTOHEMAGGLUTININ-STIMULATED HUMAN LYMPHOCYTES.MENDELSOHN J; FOX RM; GOULIAN M et al.1975; IMMUNOL. COMMUNIC.; U.S.A.; DA. 1975; VOL. 4; NO 4; PP. 373-385; BIBL. 1 P. 1/2Article

DIACETOXYPIPERIDINIUM ANALOGS OF ACETYLCHOLINELEWIS NJ; BARKER KK; FOX RM JR et al.1973; J. MEDICIN. CHEM.; U.S.A.; DA. 1973; VOL. 16; NO 2; PP. 156-159; BIBL. 39REF.Serial Issue

A RAPID HIGH-PERFORMANCE LIQUID CHROMATOGRAPHIC METHOD FOR QUANTITATION OF 5-FLUOROURACIL IN PLASMA AFTER CONTINUOUS INTRAVENOUS INFUSIONSAMPSON DC; FOX RM; TATTERSALL MHN et al.1982; ANN. CLIN. BIOCHEM.; ISSN 0004-5632; GBR; DA. 1982; VOL. 19; NO 2; PP. 125-128; BIBL. 14 REF.Article